EICHORCondition: Prostate Cancer · Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
Despite the recognized benefits of physical activity in tertiary prevention, 60-70% of prostate cancer patients are insufficiently active. Yet 150 minutes of brisk walking per week (new WHO recommendations) is associated with a 29% reduction in cancer mortality and a 57% reduction in recurrence. Increasing patients' adherence to regular physical activity appears to be a new challenge for personalized cancer care. Personalized physical activity programmes (1) at home, (2) supported by health professionals, or (3) by peers have shown the effectiveness of regular physical activity. However, these interventions last less than 6 months and do not allow for long-term sustainability of physical activity. This study proposes to combine 3 interventions, which aim to initiate and maintain regular physical activity in prostate cancer patients: * 1-The realization of a personalized and realistic physical activity project via physical activity support devices (sport health centers) * 2-Coaching by a peer (a patient with the same disease who has reached the WHO recommendations for physical activity), who will provide motivational follow-up * 3-Support by health professionals (attending physician) through the prescription of physical activity. The feasibility of ACTI-PAIR program has been demonstrated, the investigators now wish to evaluate it effectiveness.
This description comes directly from the study's public registry record.
HUPIN DAVID, MD · (0)477828413 · David.Hupin@chu-st-etienne.fr
Amandine BAUDOT, CRA · (0)477829450 · amandine.baudot@chu-st-etienne.fr
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: Patients: * Age ≥ 18 years * Diagnosed with prostate cancer for at least 1 year * PA practice \< 150 minutes per week (considered inactive according to WHO) * Affiliated or entitled to a social security scheme * Having received informed information about the study and having co-signed, with the investigator, a consent to participate in the study Exclusion Criteria: For patients: * Undergoing treatment (except hormone therapy) * Significant comorbidities contraindicating the practice of physical activity: associated cardiac pathologies, respiratory pathologies, disabling joint pathologies * Deprived of liberty or under guardianship
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Activité Physique Adaptée - CDOS Savoie | Chambéry, France | Not Yet Recruiting |
| CH Chambéry | Chambéry, France | Not Yet Recruiting |
| Activité Physique Adaptée - DAHLIR 63 | Clermont-Ferrand, France | Not Yet Recruiting |
| CHU Clermont-Ferrand - ONCOLOGIE | Clermont-Ferrand, France | Not Yet Recruiting |
| CHU Clermont-Ferrand - Urologie | Clermont-Ferrand, France | Not Yet Recruiting |
| Activité Physique Adaptée - CDOS Isère | Grenoble, France | Not Yet Recruiting |
| CHU Grenoble - Urologie | Grenoble, France | Not Yet Recruiting |
| Activité Physique Adaptée - DAHLIR 43 | Le Puy-en-Velay, France | Not Yet Recruiting |
| CH Le Puy en Velay | Le Puy-en-Velay, France | Not Yet Recruiting |
| HCL - Hôpital Edouard Herriot | Lyon, France | Not Yet Recruiting |
| HCL - Hôpital Croix Rousse | Lyon, France | Not Yet Recruiting |
| Activité Physique Adaptée - DAHLIR 69 | Lyon, France | Not Yet Recruiting |
+ 13 more locations — full list on the registry record.
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05739565